Vitamin Usage Patterns in the Prevention of Advanced Age-Related Macular Degeneration

Ophthalmology

Volumn 115, Issue 6, 2008, Pages

  Charkoudian, Leon D ^a   Gower, Emily W ^b   Solomon, Sharon D ^b   Schachat, Andrew P ^c   Bressler, Neil M ^b   Bressler, Susan B ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; MULTIVITAMIN;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EYE CARE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; RETINA MACULA AGE RELATED DEGENERATION; TERTIARY HEALTH CARE; VITAMIN SUPPLEMENTATION;

EID: 44449164083     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.08.003     Document Type: Article

References (22)

1. Kocur I., and Resnikoff S. Visual impairment and blindness in Europe and their prevention. Br J Ophthalmol 86 (2002) 716-722
2. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122 (2004) 477-485
3. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
4. van Leeuwen R., Klaver C.C., Vingerling J.R., et al. Epidemiology of age-related maculopathy: a review. Eur J Epidemiol 18 (2003) 845-854
5. Wang J.J., Foran S., and Mitchell P. Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. Clin Exp Ophthalmol 28 (2000) 268-273
6. Klaver C.C., Wolfs R.C., Vingerling J.R., et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116 (1998) 653-658
7. Munoz B., West S.K., Rubin G.S., et al. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol 118 (2000) 819-825
8. Attebo K., Mitchell P., and Smith W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology 103 (1996) 357-364
9. National Advisory Eye Council. Vision research: a national plan: 1999-2003. Report of the Retinal Diseases Panel (1998), U.S. Department of Health and Human Services, Bethesda, Maryland 42-44 NIH Publication 98-4288
10. Age-Related Eye Disease Study Research Group. AREDS report no. 8. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for advanced age-related macular degeneration and vision loss. Arch Ophthalmol 119 (2001) 1417-1436
11. American Academy of Ophthalmology. Age-related macular degeneration. Preferred practice pattern (2006), American Academy of Ophthalmology, San Francisco 11-16. http://www.aao.org/education/guidelines/ppp/amd_new.cfm Available at: http://www.aao.org/education/guidelines/ppp/amd_new.cfm. Accessed June 1, 2007.
12. Omenn G.S., Goodman G.E., Thornquist M.D., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334 (1996) 1150-1155
13. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330 (1994) 1029-1035
14. Age-Related Eye Disease Study Research Group. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol 121 (2003) 1621-1624
15. Brown D.M., Kaiser P.K., Michels M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
16. Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
17. Jampol L.M. AREDS-two years later. Arch Ophthalmol 121 (2003) 1634-1636
18. Chang C.W., Chu G., Hinz B.J., and Greve M.D. Current use of dietary supplementation in patients with age-related macular degeneration. Can J Ophthalmol 38 (2003) 27-32
19. Goujard C., Bernard N., Sohier N., et al. Impact of a patient education program on adherence to HIV medication: a randomized clinical trial. J Acquir Immune Defic Syndr 34 (2003) 191-194
20. Barth R., Campbell L.V., Allen S., et al. Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes. Diabet Med 8 (1991) 111-117
21. Alm-Roijer C., Stagmo M., Uden G., and Erhardt L. Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease. Eur J Cardiovasc Nurs 3 (2004) 321-330
22. Arora S., Musadiq M., Mukherji S., and Yang Y.C. Eye nutrient products for age-related macular degeneration: what do they contain?. Eye 18 (2004) 470-473